IBM is set to rocket if it can break $140 in 2022.
Create a massive green leg, still is looking pretty long.
Fundamentally they have done the work to focus strictly on cloud business which is expected to grow year over year.
Daily MACD continue green yesterday . Shares to borrow and short has dried up.
Moving in a triangle strenght to 140$, then looking for small retracement and then we will waiting for triangle breakout and conirmation for 150$ and more.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
Create a massive green leg, still is looking pretty long.
Fundamentally they have done the work to focus strictly on cloud business which is expected to grow year over year.
Daily MACD continue green yesterday . Shares to borrow and short has dried up.
Moving in a triangle strenght to 140$, then looking for small retracement and then we will waiting for triangle breakout and conirmation for 150$ and more.
Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。